Skip to content
healthcare.dev

INVEGA SUSTENNA

NDC 50458-563, paliperidone palmitate, injection, from Janssen Pharmaceuticals, Inc..

Product NDC
50458-563
Status
Listed
Labeler
Janssen Pharmaceuticals, Inc.
Dosage form
INJECTION
Route
INTRAMUSCULAR
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA022264
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/50458-563 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • PALIPERIDONE PALMITATE156 mg/mL

Pharmacologic classes

Atypical Antipsychotic [EPC]

Package NDCNDC-11Package
50458-563-01504580563011 SYRINGE in 1 KIT (50458-563-01) / 1 mL in 1 SYRINGE
50458-563-03504580563031 SYRINGE in 1 KIT (50458-563-03) / 1 mL in 1 SYRINGE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/1af14e42-951d-414d-8564-5d5fce138554
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=50458-563
  • NADAC price for package 50458056301

    GET /v1/drugs/nadac/50458056301

Use it

Look up 50458-563 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/50458-563 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 50458-563. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.